Monogram Biosciences To Present at the 25th Annual JPMorgan Healthcare Conference

SOUTH SAN FRANCISCO, Calif., Jan. 2 /PRNewswire-FirstCall/ — Monogram Biosciences, Inc. announced today that William D. Young, CEO and Chairman, is scheduled to present a corporate overview at the 25th Annual JPMorgan Healthcare Conference on Thursday, January 11, 2007 at 9:00 a.m. Pacific Time (12:00 p.m. Eastern Time) at the Westin St. Francis Hotel in San Francisco, California.

To access the live audio broadcast or the subsequent archived recording, log on to http://www.monogrambio.com/ and go to the investor relations section to the link provided on the Event Calendar page.

About Monogram Biosciences, Inc.

Monogram is advancing individualized medicine by discovering, developing and marketing innovative products to guide and improve treatment of serious infectious diseases and cancer. The Company’s products are designed to help doctors optimize treatment regimens for their patients that lead to better outcomes and reduced costs. The Company’s technology is also being used by numerous biopharmaceutical companies to develop new and improved antiviral therapeutics and vaccines as well as targeted cancer therapeutics. More information about the Company and its technology can be found on its web site at http://www.monogrambio.com/.

   contacts:  Alfred G. Merriweather    Jeremiah Hall              Chief Financial Officer   Feinstein Kean Healthcare              Tel: 650 624-4576         Tel: 415 677-2700              amerriweather@            jeremiah.hall@              monogrambio.com           fkhealth.com  

Monogram Biosciences, Inc.

CONTACT: Alfred G. Merriweather, Chief Financial Officer of MonogramBiosciences, Inc., +1-650-624-4576, or amerriweather@monogrambio.com; orJeremiah Hall of Feinstein Kean Healthcare, +1-415-677-2700, orjeremiah.hall@fkhealth.com

Web site: http://www.monogrambio.com/